HLS Therapeutics Partners with Bayer to Commercialize Verquvo in Canada HLS Therapeutics has entered into an agreement with Bayer to commercialize Verquvo (vericiguat) in Canada, marking HLS’s entry i...
Takeaways: Health Canada’s approval positions GSK as a first mover in Canada’s chronic hepatitis B market with the first and only finite therapy indicated to achieve functional cure....
